Instructions Bronchostop lozenges 59.5 mg blister No. 20
Composition
1 lozenge contains:
active ingredient: dry thyme herb extract (Thymi herba) (7-13:1) (extractant: water) 59.5 mg;
excipients: acacia; maltodextrin; fructose; sorbitol solution, non-crystallizing (E 420); anhydrous citric acid; sodium saccharin; chokeberry flavor; berry flavor; mineral oil; white wax; purified water.
Dosage form
Lozenges.
Main physicochemical properties: hexagonal-shaped lozenges, dark brown in color with a fruity taste.
Pharmacotherapeutic group
Combined drugs used in case of cough and colds.
ATX code R05C A.
Pharmacological properties
Pharmacodynamics
A traditional herbal medicinal product used as an expectorant for coughs associated with colds, mainly in long-term therapy. The essential oils and flavonoids of thyme herb have a bronchodilator, secretolytic and antibacterial effect, thus contributing to the rapid dissolution of phlegm accumulated in the respiratory tract, reducing cough, facilitating breathing, and also affecting the causative agent of the infection.
The special formulation of the excipient – a natural base (African acacia gum) – promotes the slow release of the active ingredient, which causes a gradual cessation of secretion by the mucous membranes, thereby reducing irritation of the mucous membranes, activating salivation and thus moisturizing the mucous membrane, thereby further relieving irritation from coughing and stopping coughing. Quickly and for a long time protects the receptors of the respiratory tract mucosa from irritation.
Pharmacokinetics
Flavonoids of thyme herb (apigenin, luteolin) are broken down by intestinal microflora and are well absorbed. They are excreted from the body mainly with urine in unchanged form or in the form of metabolites.
Indication
Symptomatic treatment of inflammatory diseases of the respiratory tract accompanied by cough and difficulty in expectorating thick sputum, relief of dry cough and relief of irritation of the mucous membrane of the mouth and pharynx.
Contraindication
- Hypersensitivity to the components of the drug or other plants of the Lamiaceae family, as well as sensitive to celery and birch pollen (cross-reaction is possible);
- children who have a history of acute stenosing laryngotracheitis;
- asthma.
Interaction with other medicinal products and other types of interactions
Interaction studies have not been conducted.
Application features
If during treatment with the drug the symptoms worsen and/or shortness of breath, fever, purulent sputum appear, you should consult a doctor. If the symptoms persist for one week, you should consult a doctor.
Contains fructose and sorbitol, so if the patient has been diagnosed with an intolerance to some sugars, you should consult a doctor before taking this medicine.
1 lozenge corresponds to approximately 0.1 carbohydrate unit. This should be taken into account by patients with diabetes.
Due to the risk of accidentally swallowing a whole lozenge, it is not recommended for use in children under 6 years of age.
Use during pregnancy or breastfeeding
Due to the lack of sufficient data, it is not recommended to use the drug during these periods.
Ability to influence reaction speed when driving vehicles or other mechanisms
Not installed.
Method of administration and doses
For oral use (use until completely dissolved in the oral cavity).
Adults and children over 12 years of age should take 1-2 lozenges every 3-4 hours (4-6 times a day). Children 6 to 12 years of age should take 1 lozenge three times a day.
If symptoms worsen or the expected effect is not achieved within 5 days, you should consult a doctor immediately.
Children
Use for children aged 6 and over.
Overdose
There are no data on cases of overdose.
In case of accidental overdose, you should consult a doctor.
Adverse reactions
Hypersensitivity reactions, including anaphylactic shock and angioedema, have been reported with thyme-containing products. Shortness of breath, rash, urticaria, and gastrointestinal disturbances (including cramps, nausea, vomiting, and diarrhea) may occur.
If any adverse reactions occur, you should consult a doctor.
Expiration date
3 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
10 lozenges in a blister, 2 blisters with instructions for medical use in a cardboard box.
Vacation category
Without a prescription.
Producer
Kwizda Pharma GmbH/Kwizda Pharma GmbH.
Location of the manufacturer and its business address
Effingergasse 21, 1160 Vienna, Austria.
Kwizda Pharma GmbH/Kwizda Pharma GmbH.
Location of the manufacturer and its business address.
Effingergasse 21, 1160 Vienna, Austria.
